课题基金 / 基金详情

MECHANISMS OF IONTOPHORETIC DRUG DELIVERY ACROSS SKIN

MECHANISMS OF IONTOPHORETIC DRUG DELIVERY ACROSS SKIN
离子电渗疗法跨皮肤给药的机制
批准号:
3329508
负责人:
RICHARD H GUY
金额:
$17.52万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-08-01 至 1994-07-31

项目摘要

项目成果

RICHARD H GUY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long-term objective of this research is to extend significantly the range of drugs for which transdermal delivery is a viable administration route. In particular, experiments are described to explore the potential of the skin as a systemic portal for new peptide and protein therapeutic agents emerging from the biotechnology industry. The focus of the proposal is to determine the feasibility and optimization of skin penetration enhancement by iontophoresis - the facilitation of (ionizable drug delivery across the skin by an applied electrical potential. The specific aims are to address the basic questions: By what mechanism(s) does iontophoresis enhance op iontophoresis dependent upon, and constrained by, penetrant properties? Iontophoresis concentrates attention on drug transport across the stratum corneum (SC, the outermost and least permeable skin layer) via "pores". The predominantly in vitro work proposed will: (a) use fluorescent probes and confocal microscopy to visualize routes of ionic flow across SC, (b) vectorize ionic transport with the vibrating probe electrode technique, (c) determine basic penetrant structure/properties-iontophoretic enhancement relationships, (d) develop the theoretical understanding of iontophoretic enhancement. Model penetrants for these experiments will be specifically designed peptide derivatives. Overall, a detailed examination of skin transport promotion by electrical means is outlined. In particular, the feasibility and optimization of peptide/small protein delivery, for which few acceptable alternatives exist, will be addressed.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
Transdermal delivery of peptides by iontophoresis.
通过离子电渗疗法透皮递送肽。
DOI: 10.1038/nbt1296-1710
发表时间: 1996
期刊: Nature biotechnology.
影响因子: --
作者: [Hirvonen,J, Kalia,YN, Guy,RH]
通讯作者: Guy,RH
Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment.
单体胰岛素类似物的体外离子电渗疗法:胰岛素电荷和皮肤预处理的影响。
DOI: 10.1016/s0168-3659(97)00155-7
发表时间: 1998
期刊: Journal of controlled release : official journal of the Controlled Release Society
影响因子: --
作者: [Langkjaer,L, Brange,J, Grodsky,GM, Guy,RH]
通讯作者: Guy,RH
Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances.
穿过皮肤的离子电渗传递:电渗及其药物的调节。
DOI: 10.1023/a:1012127512251
发表时间: 1997
期刊: Pharmaceutical research
影响因子: 3.7
作者: [Hirvonen,J, Guy,RH]
通讯作者: Guy,RH
Iontophoresis of nafarelin across human skin in vitro.
那法瑞林在体外穿过人体皮肤的离子电渗疗法。
DOI: 10.1023/a:1016072205371
发表时间: 1996
期刊: Pharmaceutical research
影响因子: 3.7
作者: [RodríguezBayón,AM, Guy,RH]
通讯作者: Guy,RH
6
    Assessing the skin pharmacokinetics of topical drugs, and the bio(in)equivalence of topical drug products, using non-invasive techniques
    • 批准号:
      10223914
    • 项目类别:
    • 资助金额:
      $25.0万
    • 财政年份:
      2018
    • 负责人:
      RICHARD H GUY
    • 依托单位:
    Assessing the skin pharmacokinetics of topical drugs, and the bio(in)equivalence of topical drug products, using non-invasive techniques
    • 批准号:
      10469997
    • 项目类别:
    • 资助金额:
      $24.99万
    • 财政年份:
      2018
    • 负责人:
      RICHARD H GUY
    • 依托单位:
    Assessing the skin pharmacokinetics of topical drugs, and the bio(in)equivalence of topical drug products, using non-invasive techniques
    • 批准号:
      9770854
    • 项目类别:
    • 资助金额:
      $25.0万
    • 财政年份:
      2018
    • 负责人:
      RICHARD H GUY
    • 依托单位:
    Skin Bioengineering: Noninvasive Transdermal Monitoring
    • 批准号:
      6794694
    • 项目类别:
    • 资助金额:
      $24.3万
    • 财政年份:
      2003
    • 负责人:
      RICHARD H GUY
    • 依托单位:
    海外基金